Global Markets for Allergy Diagnostics and Treatments

Report Code: PHM026B

Publish Date: Feb 2015

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

Global allergy diagnostic and treatment market is projected to increase to nearly $35.3 billion by 2015 from $31.5 billion in 2014. This market is expected to reach $46.8 billion by 2020, corresponding to a compound annual growth rate (CAGR) of 5.8% during 2015 to 2020 period.

Report Includes

  • An overview of the global markets for allergy diagnostics and treatments.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
  • Segmentation of the market into diagnostics, prescription treatments, and over-the-counter (OTC) treatments.
  • Information on different types of allergic reactions, including anaphylactoid reactions, cytotoxic and cytolytic reactions, immune complex reactions, and delayed hypersensitivity reactions.
  • Profiles of major players in the allergy diagnostics and treatments industry.

SCOPE OF REPORT

This BCC Research report is designed to provide a comprehensive look at the global allergy diagnostic, immunotherapy, and treatment markets. The geographic areas covered by the report include the Americas region (i.e., Canada, U.S., Mexico, and Central and South America); the EMRA region (i.e., Europe, the Middle East, Russia, and Africa); and the Asian region (i.e., Japan, China, India, Australia, New Zealand, and other Asian Pacific countries).

The report provides a brief explanation of different allergic disorders with global incidence rates; discusses the different types of allergy diagnostic tests and their applicability in diagnosing various allergens; describes classes of allergy treatment products; and provides an overview of the growing immunotherapy market. The report organizes information from diverse sources into a cohesive unit that includes:

  • A section on diagnostic products such as skin prick and patch tests, provocation testing, and antibody allergen testing.
  • An overview section on allergies and five categories of prescription allergy products including antihistamines and combinations; sympathomimetics, decongestants and combinations; corticosteroids; mast cell stabilizers; and leukotriene receptors.
  • Specific chapters that focus on testing and treatment in three distinct geographical areas: Americas, EMRA and Asia.
  • A company profiles section that provides background information on companies active in the diagnostic and treatment arenas.

Prescription and over-the-counter (OTC) medications are further broken down into specific types of administration. Each subsegment is covered in depth with regard to oral, spray, topical, and ocular applications; current treatments, market size, and market participants; potential research and development; and forecasted market size and growth.

ANALYST’S CREDENTIALS

Peggy S. Lehr is the BCC research analyst of this report. Ms. Lehr holds a Bachelor of Science degree in Journalism from the University of Colorado, Boulder, and a Master of Science degree in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 25 years, and she has worked within the publishing industry for both for-profit and not-for-profit organizations. Recent reports for BCC include health care reports on catheters, magnetic resonance imaging, organ transplantation, asthma and chronic obstructive pulmonary disease (COPD), and autoimmune diseases, and her latest report on the global sterilization market.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Allergy Diagnostics and Treatments130Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY5Free
Chapter- 3: OVERVIEW OF ALLERGIES 18Free
Chapter- 4: GLOBAL ALLERGY DIAGNOSTICS MARKET21Free
Chapter- 5: GLOBAL IMMUNOTHERAPY MARKET15Free
Chapter- 6: GLOBAL ALLERGY TREATMENT MARKET40Free
Chapter- 7: DEVELOPMENTS IN ALLERGY TESTING AND TREATMENT AND RECENT PATENTS 15Free
Chapter- 8: C. CRAMER & CO. GMBH13Free
Published - Jun-2002| Analyst - Mary Anne Crandall| Code - PHM026A

Report Highlights

  • The total, current U.S. prescription allergy treatment and management market in 2001 generated revenues of $6.45 billion. In 2006, this market is forecast to reach $9.6 billion, rising at an average annual growth rate (AAGR) of 8.3%.
  • The antihistamines and combinations segment reached $2.90 billion in 2001, some 45% of the market. Growing at an AAGR of 6.7%, this segment will reach $4 billion in 2006, but will lose ground to corticosteroids.
  • Corticosteroids are expected to rise the fastest, at an AAGR of 11.8% to $3.98 billion in 2006, representing 41.5% of the market at that time.
  • The mast cell stabilizers segment will be the second fastest growing and will rise at an AAGR of 8.9% from $340 million in 2001 to $520 million in 2006.
  • Sympathomimetics, decongestants and combinations were valued at $930 million in 2001 and will rise at an AAGR of only 3.2% to $1.09 billion in 2006.

Related Reports

Markets for Advanced Wound Management Technologies

Published - Jun 2014 | Publisher - Melissa Elder | Code - PHM011H

The global market for advanced wound management totaled $8.6 billion in 2013, up from 2011’s value of $7.9 billion. By 2018, this market is likely to reach $11.3 billion, a compound annual growth rate (CAGR) of 5.6%.

Antibiotics: Technologies and Global Markets

Published - May 2014 | Publisher - Neha Maliwal | Code - PHM025C

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

Therapeutics for Women's Health: Technologies and Global Markets

Published - May 2014 | Publisher - Dr. Ritu Thakur Dangi | Code - BIO043E

The global market for women’s health therapeutics was worth nearly $18.3 billion in 2012. The market is expected to increase from nearly $19 billion in 2013 to nearly $22.5 billion by 2018, a compound annual growth rate (CAGR) of 3.5% for the five-year period, 2013 to 2018.

The Global Blood Industry

Published - Jun 2013 | Publisher - Melissa Elder | Code - HLC008H

The global market for blood products reached $23.5 billion in 2012. The market is expected to reach $28.8 billion in 2017 for a compound annual growth rate (CAGR) of 4.1%.

Recent Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

Rare Disease Diagnostics: Technologies and Global Markets

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM227B

The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.

Breakthrough Therapies: Market Dynamics and Investment Opportunities

Published - Dec 2024 | Publisher - BCC Publishing | Code - PHM176B

The global market for breakthrough therapy drugs was valued at $133.3 billion in 2023. This market is expected to grow from $150.6 billion in 2024 to $287.5 billion by 2029, at a compound annual growth rate (CAGR) of 13.8% from 2024 to 2029.

Softgel Capsules: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM244B

The global market for softgel capsules was valued at $7.4 billion in 2023. The market is expected to grow from $7.9 billion in 2024 to $11.5 billion by 2029, at a compound annual growth rate, or CAGR, of 7.7% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Top Trending Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO208C

The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.

Medical Devices Industry: Competitive Landscape

Published - Nov 2024 | Publisher - BCC Publishing | Code - MDS010C

The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Market Opportunities and Competitive Landscape for CDMO

Published - Nov 2024 | Publisher - BCC Publishing | Code - PHM238B

The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Allergy Diagnostics and Treatments
Customize Report